World Medicine, Pharmaceuticals & Biotechnology Markets Analyzed in New Reports Published at MarketPublishers.com

27 Dec 2011 • by Natalie Aster

LONDON - Market Publishers Ltd informs that new topical Visiongain reports on medicine, pharmaceuticals & biotechnology markets have been added to its catalogue.

Antibacterial Drugs: World Market Prospects 2012-2022. What are the commercial prospects for antibacterial treatments? How will 20 leading products perform to 2022? What does the future hold? The report provides answers all these questions, including revenue forecasts, possible sales trends for antibiotics, growth rates, market shares, qualitative analyses (including SWOT and STEP), an R&D review and opinions of industry experts …

Advanced Wound Care: World Market Prospects 2011-2021. The adoption of expensive but more effective wound care devices and biologics will increase in the developed countries in years to come. Forecasts say the overall advanced wound care market will be worth USD 6.7 billion in 2011. The report is designed to give in-depth analysis of the global advanced wound care market over the next decade, providing detailed forecasts for its three main segments. Sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including SWOT analysis can also be found in the study …

Medical Device Contract Manufacturing: World Market Outlook 2011-2021. Nowadays, medical device outsourcing companies can offer services ranging from product development, design, manufacturing, engineering, and pre-clinical testing to supply chain management (sterilization, packaging and warehousing). The report provides an assessment of the current and future state of the medical device contract manufacturing market, with respect to the three leading segments (material processing, electronics, and finished products), products, companies and national markets …

Multiple Sclerosis Treatment: World Drug Market 2012-2022. The report delves into detailed analysis of the multiple sclerosis (MS) drug market. It features potential revenue for the market as well as sales growth; revenue forecasts for key MS drugs; assesses leading companies along with their activities and prospects; revenue forecasts for leading national markets; R&D for treating MS as well as pipeline trends; competition and opportunities influencing the industry and its sales; various market drivers and restraints …

More new market research reports by the publisher can be found at Visiongain page.

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com